ArticleMolecular cancer therapeutics2023

T Cell-intrinsic Immunomodulatory Effects of TAK-981 (Subasumstat), a SUMO-activating Enzyme Inhibitor, in Chronic Lymphocytic Leukemia.

Vi Lam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.